1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Novartis India Limited

Novartis India Limited

NOVARTIND.NS
Novartis India LimitedIN flagNational Stock Exchange of India
1,460.00
INR
+2.60
- -
36.09BMarket Cap

Total Valuation

Novartis India Limited carries a market capitalization of 36.09B, placing it among publicly traded companies globally. Its enterprise value stands at -6.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap36.09B
Enterprise Value-6.65B

Share Statistics

Novartis India Limited currently has 24.69M shares outstanding.

Shares Outstanding24.69M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Financial Position

Novartis India Limited maintains a current ratio of 5.30, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.39, indicating conservative leverage, while an interest coverage ratio of 59.70 demonstrates strong ability to service its debt obligations.

Current Ratio5.30
Quick Ratio4.61
Debt / Equity0.39
Debt / EBITDA0.05
Interest Coverage59.70

Financial Efficiency

Novartis India Limited posts a return on equity of 17.38 and a return on invested capital of 5.96.

Return on Equity (ROE)17.38
Return on Assets (ROA)7.16
Return on Invested Capital (ROIC)5.96
Return on Capital Employed (ROCE)17.40
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.13

Taxes

Over the trailing twelve months, Novartis India Limited has paid 280.50M in income taxes, reflecting an effective tax rate of 28.91.

Income Tax280.50M
Effective Tax Rate28.91

Stock Price Statistics

Novartis India Limited's stock has gained approximately 45.9854% over the past 52 weeks. The 50-day moving average sits at 1,302.71, while the 200-day moving average is 1,237.65.

Beta (5Y)N/A
52-Week Price Change45.9854%
50-Day Moving Average1,302.71
200-Day Moving Average1,237.65
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Novartis India Limited generated 2.64B in revenue and converted that into 689.60M in net income, yielding earnings per share of 27.94. EBITDA reached 686.60M, while operating income came in at 686.60M.

Revenue2.64B
Gross Profit1.16B
Operating Income686.60M
Pretax Income970.10M
Net Income689.60M
EBITDA686.60M
EBIT686.60M
Earnings Per Share (EPS)27.94

Balance Sheet

Novartis India Limited holds 6.68B in cash and equivalents against 32.10M in total debt, resulting in a net debt position of -525.00M. Total book value stands at 123.40M, with working capital of 6.23B providing operational flexibility.

Cash & Cash Equivalents6.68B
Total Debt32.10M
Net Debt-525.00M
Equity (Book Value)123.40M
Book Value Per Share5.00
Working Capital6.23B

Margins

Novartis India Limited operates with a gross margin of 44.00, reflecting its pricing power and cost economics. The operating margin of 26.01 and net profit margin of 26.12 provide insight into operational efficiency.

Gross Margin44.00
Operating Margin26.01
Pretax Margin36.75
Profit Margin26.12
EBITDA Margin26.01

Scores

Novartis India Limited posts an Altman Z-Score of 1.27, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.27